BRLF1 Polyclonal Antibody, PE-Cy7 Conjugated
Product Specifications
Background
Immediate-early transcription factor that controls the initiation of viral lytic gene expression and lytic reactivation from latency. Triggers lytic replication, and initiates a cellular senescence program in epithelial cells. Upregulates human DCR3/TNFRSF6B by directly binding to its receptor.
Synonyms
Replication and transcription activator; Rta; Immediate-early protein Rta; BRLF1
Gene ID
3783727
Swiss Prot
P03209
Host
Rabbit
Cross Reactivity
Human, Virus
Immunogen
81-180/605
Target
BRLF1
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from Epstein-Barr virus Replication and transcription activator
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
1µg/µl
Dilution
WB (WB=1:500-2000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
3783727
Cross Reactivity Details
HHV4tp2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS649463-01 0.05 mg
PIP4K2C (Phosphatidylinositol 5-phosphate 4-kinase Type-2 gamma, Phosphatidylinositol 5-phosphate 4-kinase Type II gamma, PI(5)P 4-kinase Type II gamma, PIP4KII-gamma, PIP5K2C, FLJ22055)
Ask
View Details MBS649463-02 5x 0.05 mg
PIP4K2C (Phosphatidylinositol 5-phosphate 4-kinase Type-2 gamma, Phosphatidylinositol 5-phosphate 4-kinase Type II gamma, PI(5)P 4-kinase Type II gamma, PIP4KII-gamma, PIP5K2C, FLJ22055)
Ask
View Details 
